[go: up one dir, main page]

NO940844L - Farmasöytisk aktive hydroksykarboksylsyrederivater - Google Patents

Farmasöytisk aktive hydroksykarboksylsyrederivater

Info

Publication number
NO940844L
NO940844L NO940844A NO940844A NO940844L NO 940844 L NO940844 L NO 940844L NO 940844 A NO940844 A NO 940844A NO 940844 A NO940844 A NO 940844A NO 940844 L NO940844 L NO 940844L
Authority
NO
Norway
Prior art keywords
acid derivatives
pharmaceutically active
hydroxycarboxylic acid
active hydroxycarboxylic
compounds
Prior art date
Application number
NO940844A
Other languages
English (en)
Other versions
NO940844D0 (no
Inventor
Andreas Billich
Brigitte Charpiot
Peter Ettmayer
Hubert Gstach
Philipp Lehr
Dieter Scholz
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB939305144A external-priority patent/GB9305144D0/en
Priority claimed from GB939319667A external-priority patent/GB9319667D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of NO940844D0 publication Critical patent/NO940844D0/no
Publication of NO940844L publication Critical patent/NO940844L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40—Acylated substituent nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/04—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
    • C07C275/06—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton
    • C07C275/16—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton being further substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/70—Sulfur atoms
    • C07D277/74—Sulfur atoms substituted by carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Oppfinnelsen vedrører forbindelser med formel I R.-A-NH-CH-CH-CH-CO-B-NH-R4 4 l 2 1 OH hvor substituentene A, B, R1( R2, R3 og R4 har en rekke angitte betydninger. Forbindelsen kan fremstilles ved konvensjonelle metoder, f.eks. ved reaksjoner som kopling, substitusjon, avbeskyttelse eller beskyttelse. Forbindelsene utviser interessante farmakologiske egenskaper og er således indikert for anvendelse i behandling av retrovirusinfeksjoner, særlig som HIV-proteinaseinhibitorer.
NO940844A 1993-03-12 1994-03-10 Farmasöytisk aktive hydroksykarboksylsyrederivater NO940844L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939305144A GB9305144D0 (en) 1993-03-12 1993-03-12 Organic compounds
GB939319667A GB9319667D0 (en) 1993-09-23 1993-09-23 Organic compounds

Publications (2)

Publication Number Publication Date
NO940844D0 NO940844D0 (no) 1994-03-10
NO940844L true NO940844L (no) 1994-09-13

Family

ID=26302578

Family Applications (1)

Application Number Title Priority Date Filing Date
NO940844A NO940844L (no) 1993-03-12 1994-03-10 Farmasöytisk aktive hydroksykarboksylsyrederivater

Country Status (16)

Country Link
US (1) US5538997A (no)
EP (1) EP0615969A1 (no)
JP (1) JP3987586B2 (no)
KR (1) KR940021515A (no)
CN (1) CN1104209A (no)
AU (1) AU672867B2 (no)
CA (1) CA2118876A1 (no)
CZ (1) CZ55394A3 (no)
FI (1) FI941149A7 (no)
HU (1) HUT71793A (no)
IL (1) IL108930A0 (no)
NO (1) NO940844L (no)
NZ (1) NZ260063A (no)
PE (1) PE15695A1 (no)
SK (1) SK30394A3 (no)
TW (1) TW260662B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5863902A (en) * 1995-01-06 1999-01-26 Sibia Neurosciences, Inc. Methods of treating neurodegenerative disorders using protease inhibitors
US5804560A (en) * 1995-01-06 1998-09-08 Sibia Neurosciences, Inc. Peptide and peptide analog protease inhibitors
US6008228A (en) * 1995-06-06 1999-12-28 Hoffman-La Roche Inc. Pharmaceutical compositions containing proteinase inhibitors
ATE218538T1 (de) * 1995-11-21 2002-06-15 Novartis Erfind Verwalt Gmbh Azahexan-derivate als substratisostere von retroviralen aspartat-proteasen
ATE270268T1 (de) * 1999-04-27 2004-07-15 Novartis Pharma Gmbh 2,4-diamino-3-hydroxycarboxylsäurederivate als proteasome inhibitoren
GB0012795D0 (en) * 2000-05-25 2000-07-19 Novartis Ag Organic compounds
HUP0303540A2 (hu) * 2000-12-20 2004-01-28 Bristol-Myers Squibb Pharma Co. Diaminok mint kemokin receptor aktivitás modulátorai, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
CA2453447A1 (en) * 2001-07-10 2003-01-23 Elan Pharmaceuticals, Inc. Alpha-hydroxyamide statine derivatives for the treatment of alzheimer's disease
US20240132484A1 (en) * 2020-12-03 2024-04-25 University Of Maryland, Baltimore Broad spectrum antiviral compounds targeting the ski complex

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4661473A (en) * 1984-03-27 1987-04-28 Merck & Co., Inc. Renin inhibitors containing peptide isosteres
IL89900A0 (en) * 1988-04-12 1989-12-15 Merck & Co Inc Hiv protease inhibitors useful for the treatment of aids and pharmaceutical compositions containing them
CA2032259A1 (en) * 1989-12-18 1991-06-19 Wayne J. Thompson Hiv protease inhibitors useful for the treatment of aids
CA2052892A1 (en) * 1990-10-11 1992-04-12 Suresh K. Balani Inhibitors of hiv protease
CA2109326A1 (en) * 1991-07-02 1993-01-03 Andreas Billich 4-amino-3-hydroxycarboxylic acid derivatives
GB9210744D0 (en) * 1992-05-20 1992-07-08 Pfizer Ltd Antiviral peptides

Also Published As

Publication number Publication date
PE15695A1 (es) 1995-06-13
KR940021515A (ko) 1994-10-19
JP3987586B2 (ja) 2007-10-10
IL108930A0 (en) 1994-06-24
AU5773794A (en) 1994-09-15
FI941149L (fi) 1994-12-22
AU672867B2 (en) 1996-10-17
TW260662B (no) 1995-10-21
NZ260063A (en) 1996-02-27
US5538997A (en) 1996-07-23
HU9400745D0 (en) 1994-06-28
SK30394A3 (en) 1995-03-08
FI941149A7 (fi) 1994-12-22
CA2118876A1 (en) 1994-09-13
CZ55394A3 (en) 1995-04-12
EP0615969A1 (en) 1994-09-21
FI941149A0 (fi) 1994-03-10
NO940844D0 (no) 1994-03-10
HUT71793A (en) 1996-02-28
CN1104209A (zh) 1995-06-28
JPH0789919A (ja) 1995-04-04

Similar Documents

Publication Publication Date Title
HK129093A (en) N-tert-butyl-decahydro-2(3-amino-2-hydroxy-4-phenyl-butyl)isoquinoline-3-carboxamide & asparaginyl derivatives thereof
NO20061170L (no) Piperazinderivater for behandling av HIV-infeksjoner
CA2398620A1 (en) Pyrazine derivatives, pharmaceutical compositions containing them, and intermediates therefor
CA2349338A1 (en) Novel macrolide antibiotics
NO940844L (no) Farmasöytisk aktive hydroksykarboksylsyrederivater
CA2286511A1 (en) Novel macrolide derivatives
IL112020A0 (en) Arylacetic acid derivatives, their preparation and their use as fungicides
CA2187110A1 (en) Benzamide derivative, compositions containing said derivative and use thereof
IL98970A0 (en) Cyclopentane derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
CA2060616A1 (en) Use of 4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine derivatives as free radical scavengers
AU686197B2 (en) Use of coumarins and carbostyrils as PLA2-inhibitors, new coumarins and carbostyrils, process for preparing the same and medicaments
MXPA02004441A (es) Derivados de isoxazol como inhibidores de la fosfodiesterasa.
ES2019840A6 (es) Procedimiento para preparar nuevos derivados de tieno-triazolo-diazepina.
AU534470B2 (en) Paromomycin derivatives
AP0102296A0 (en) Hygromycin A derivatives.
AU574198B2 (en) Penem derivatives
WO1990003172A3 (en) Bile acids for treatment of viral infections
CA2108817A1 (en) Arylidene-1-azacycloalkanes and arylalkyl-1-azacycloalkanes, their salts, medicaments containing these compounds and their use, and processes for their preparation
CA2352332A1 (en) Hygromycin a derivatives
JPS5533499A (en) N2-arylsulfonyl-l-arginineamide and its pharmaceutically acceptable salt
CA2111460A1 (en) Tetrahydrobenzazepine derivatives which inhibit lipoxygenase
HUT53096A (en) Process for producing thienylacetic acid derivatives and pharmaceutical compositions comprising same
JPS55164671A (en) Azetidine derivative and its preparation
RU92016472A (ru) Противовирусные средства, содержащие гетерополимолибдаты, способ лечения или профилактики инфекций, связанных с ретровирусом, применение гетерополимолибдатов для получения лекарственных средств, гетерополимолибдаты
JO1648B1 (en) Nitrogen compounds